Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicity

Nicholas B. Miner, Josh S. Elmore, Michael H. Baumann, Tamara Phillips, Aaron Janowsky

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Trace amine-associated receptor 1 (TAAR1) is activated by methamphetamine (MA) and modulates dopaminergic (DA) function. Although DA dysregulation is the hallmark of MA-induced neurotoxicity leading to behavioral and cognitive deficits, the intermediary role of TAAR1 has yet to be characterized. To investigate TAAR1 regulation of MA-induced neurotoxicity, Taar1 transgenic knock-out (KO) and wildtype (WT) mice were administered saline or a neurotoxic regimen of 4 i.p. injections, 2 h apart, of MA (2.5, 5, or 10 mg/kg). Temperature data were recorded during the treatment day. Additionally, striatal tissue was collected 2 or 7 days following MA administration for analysis of DA, 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), and tyrosine hydroxylase (TH) levels, as well as glial fibrillary acidic protein (GFAP) expression. MA elicited an acute hypothermic drop in body temperature in Taar1-WT mice, but not in Taar1-KO mice. Two days following treatment, DA and TH levels were lower in Taar1-KO mice compared to Taar1-WT mice, regardless of treatment, and were dose-dependently decreased by MA. GFAP expression was significantly increased by all doses of MA at both time points and greater in Taar1-KO compared to Taar1-WT mice receiving MA 2.5 or 5 mg/kg. Seven days later, DA levels were decreased in a similar pattern: DA was significantly lower in Taar1-KO compared to Taar1-WT mice receiving MA 2.5 or 5 mg/kg. TH levels were uniformly decreased by MA, regardless of genotype. These results indicate that activation of TAAR1 potentiates MA-induced hypothermia and TAAR1 confers sustained neuroprotection dependent on its thermoregulatory effects.

Original languageEnglish (US)
Pages (from-to)57-69
Number of pages13
JournalNeuroToxicology
Volume63
DOIs
StatePublished - Dec 1 2017

Fingerprint

Methamphetamine
Tyrosine 3-Monooxygenase
Knockout Mice
Glial Fibrillary Acidic Protein
Trace amine-associated receptor 1
Hypothermia
Corpus Striatum
Induced Hypothermia
3,4-Dihydroxyphenylacetic Acid
Homovanillic Acid
Body Temperature
Transgenic Mice
Therapeutics
Chemical activation
Genotype

Keywords

  • Dopamine
  • GFAP
  • Methamphetamine
  • Neurotoxicity
  • TAAR1
  • Temperature

ASJC Scopus subject areas

  • Neuroscience(all)
  • Toxicology

Cite this

Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicity. / Miner, Nicholas B.; Elmore, Josh S.; Baumann, Michael H.; Phillips, Tamara; Janowsky, Aaron.

In: NeuroToxicology, Vol. 63, 01.12.2017, p. 57-69.

Research output: Contribution to journalArticle

Miner, Nicholas B. ; Elmore, Josh S. ; Baumann, Michael H. ; Phillips, Tamara ; Janowsky, Aaron. / Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicity. In: NeuroToxicology. 2017 ; Vol. 63. pp. 57-69.
@article{a7c039482e78405788c3834eb7fdf548,
title = "Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicity",
abstract = "Trace amine-associated receptor 1 (TAAR1) is activated by methamphetamine (MA) and modulates dopaminergic (DA) function. Although DA dysregulation is the hallmark of MA-induced neurotoxicity leading to behavioral and cognitive deficits, the intermediary role of TAAR1 has yet to be characterized. To investigate TAAR1 regulation of MA-induced neurotoxicity, Taar1 transgenic knock-out (KO) and wildtype (WT) mice were administered saline or a neurotoxic regimen of 4 i.p. injections, 2 h apart, of MA (2.5, 5, or 10 mg/kg). Temperature data were recorded during the treatment day. Additionally, striatal tissue was collected 2 or 7 days following MA administration for analysis of DA, 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), and tyrosine hydroxylase (TH) levels, as well as glial fibrillary acidic protein (GFAP) expression. MA elicited an acute hypothermic drop in body temperature in Taar1-WT mice, but not in Taar1-KO mice. Two days following treatment, DA and TH levels were lower in Taar1-KO mice compared to Taar1-WT mice, regardless of treatment, and were dose-dependently decreased by MA. GFAP expression was significantly increased by all doses of MA at both time points and greater in Taar1-KO compared to Taar1-WT mice receiving MA 2.5 or 5 mg/kg. Seven days later, DA levels were decreased in a similar pattern: DA was significantly lower in Taar1-KO compared to Taar1-WT mice receiving MA 2.5 or 5 mg/kg. TH levels were uniformly decreased by MA, regardless of genotype. These results indicate that activation of TAAR1 potentiates MA-induced hypothermia and TAAR1 confers sustained neuroprotection dependent on its thermoregulatory effects.",
keywords = "Dopamine, GFAP, Methamphetamine, Neurotoxicity, TAAR1, Temperature",
author = "Miner, {Nicholas B.} and Elmore, {Josh S.} and Baumann, {Michael H.} and Tamara Phillips and Aaron Janowsky",
year = "2017",
month = "12",
day = "1",
doi = "10.1016/j.neuro.2017.09.006",
language = "English (US)",
volume = "63",
pages = "57--69",
journal = "NeuroToxicology",
issn = "0161-813X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicity

AU - Miner, Nicholas B.

AU - Elmore, Josh S.

AU - Baumann, Michael H.

AU - Phillips, Tamara

AU - Janowsky, Aaron

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Trace amine-associated receptor 1 (TAAR1) is activated by methamphetamine (MA) and modulates dopaminergic (DA) function. Although DA dysregulation is the hallmark of MA-induced neurotoxicity leading to behavioral and cognitive deficits, the intermediary role of TAAR1 has yet to be characterized. To investigate TAAR1 regulation of MA-induced neurotoxicity, Taar1 transgenic knock-out (KO) and wildtype (WT) mice were administered saline or a neurotoxic regimen of 4 i.p. injections, 2 h apart, of MA (2.5, 5, or 10 mg/kg). Temperature data were recorded during the treatment day. Additionally, striatal tissue was collected 2 or 7 days following MA administration for analysis of DA, 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), and tyrosine hydroxylase (TH) levels, as well as glial fibrillary acidic protein (GFAP) expression. MA elicited an acute hypothermic drop in body temperature in Taar1-WT mice, but not in Taar1-KO mice. Two days following treatment, DA and TH levels were lower in Taar1-KO mice compared to Taar1-WT mice, regardless of treatment, and were dose-dependently decreased by MA. GFAP expression was significantly increased by all doses of MA at both time points and greater in Taar1-KO compared to Taar1-WT mice receiving MA 2.5 or 5 mg/kg. Seven days later, DA levels were decreased in a similar pattern: DA was significantly lower in Taar1-KO compared to Taar1-WT mice receiving MA 2.5 or 5 mg/kg. TH levels were uniformly decreased by MA, regardless of genotype. These results indicate that activation of TAAR1 potentiates MA-induced hypothermia and TAAR1 confers sustained neuroprotection dependent on its thermoregulatory effects.

AB - Trace amine-associated receptor 1 (TAAR1) is activated by methamphetamine (MA) and modulates dopaminergic (DA) function. Although DA dysregulation is the hallmark of MA-induced neurotoxicity leading to behavioral and cognitive deficits, the intermediary role of TAAR1 has yet to be characterized. To investigate TAAR1 regulation of MA-induced neurotoxicity, Taar1 transgenic knock-out (KO) and wildtype (WT) mice were administered saline or a neurotoxic regimen of 4 i.p. injections, 2 h apart, of MA (2.5, 5, or 10 mg/kg). Temperature data were recorded during the treatment day. Additionally, striatal tissue was collected 2 or 7 days following MA administration for analysis of DA, 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), and tyrosine hydroxylase (TH) levels, as well as glial fibrillary acidic protein (GFAP) expression. MA elicited an acute hypothermic drop in body temperature in Taar1-WT mice, but not in Taar1-KO mice. Two days following treatment, DA and TH levels were lower in Taar1-KO mice compared to Taar1-WT mice, regardless of treatment, and were dose-dependently decreased by MA. GFAP expression was significantly increased by all doses of MA at both time points and greater in Taar1-KO compared to Taar1-WT mice receiving MA 2.5 or 5 mg/kg. Seven days later, DA levels were decreased in a similar pattern: DA was significantly lower in Taar1-KO compared to Taar1-WT mice receiving MA 2.5 or 5 mg/kg. TH levels were uniformly decreased by MA, regardless of genotype. These results indicate that activation of TAAR1 potentiates MA-induced hypothermia and TAAR1 confers sustained neuroprotection dependent on its thermoregulatory effects.

KW - Dopamine

KW - GFAP

KW - Methamphetamine

KW - Neurotoxicity

KW - TAAR1

KW - Temperature

UR - http://www.scopus.com/inward/record.url?scp=85029930331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029930331&partnerID=8YFLogxK

U2 - 10.1016/j.neuro.2017.09.006

DO - 10.1016/j.neuro.2017.09.006

M3 - Article

VL - 63

SP - 57

EP - 69

JO - NeuroToxicology

JF - NeuroToxicology

SN - 0161-813X

ER -